CG Oncology

CGON • NASDAQ • Stock Fundamentals

CG Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arthur Kuan, with a market cap of $5.1B.

Market Cap$5.1B

Employees61.0

CEOArthur Kuan

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 8, 2026 · 1 month 6 days agoQ1 2026

Next EarningsAug 7, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about CG Oncology

CG Oncology (CGON) has a market capitalization of $5.1B and trades on NASDAQ.

CG Oncology has approximately 61 employees.